FindTrial
Sign In

Timing of intraoperative intravenous fluid infusion on renal function after renal transplant surgery in patients with end stage renal disease

Comparison of different rates of intraoperative fluid therapy on early graft function during live related renal transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/10/010129
Enrollment
40
Registered
2017-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with End Stage Renal disease

Interventions

Intervention1: Targeted Fluid Therapy: Intravenous fluid given at the time of vascular anastomosis only Control Intervention1: Standard fluid therapy: Intravenous fluid given according to standard flu

Sponsors

Rashmi Ramachandran
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing live related renal transplant

Exclusion criteria

Exclusion criteria: Patients having severe left ventricular dysfunction with ejection fraction less than 40%, diabetes, hemoglobin less than 8 gram %, severe pulmonary disease or liver disease, majo vascular anomaly of donated organ were excluded from the study. Patients requiring intraoperative blood transfusion were excluded

Design outcomes

Primary

MeasureTime frame
Serum creatinine levelTimepoint: First Postoperative Day—

Secondary

MeasureTime frame
Graft Turgidity ScoreTimepoint: After de-clamping of anastomotic vessels;Overall intravenous fluid infused during the surgeryTimepoint: Intraoperative period—

Countries

India

Contacts

Public ContactAbhishek Singh

AIIMS, Delhi

rashmiramachandran1@gmail.com9811422188

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026